Streetbeat News

Products Services

PFE

RHHBY

Roche's Genentech has been granted Priority Review by the FDA for Inavolisib, an investigational oral therapy, in combination with Palbociclib (Ibrance) and Fulvestrant. The FDA decision is expected by November 27, 2024. This regimen targets PIK3CA-mutated, HR-positive, HER2-negative, locally advanced or metastatic breast cancer.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 5:08 am

JOYY Inc. reported its Q1 2024 operational highlights, showing a slight increase in global average mobile MAUs to 277.3 million from 272.9 million YoY. However, individual platforms like Bigo Live, Likee, and Hago saw declines in MAUs due to reduced spending on user acquisition. The total number of paying users for BIGO increased to 1.67 million from 1.57 million YoY, although the average revenue per paying user decreased to $235.4 from $244.8.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 4:56 am

SHIBUSD

WIFUSD

Memecoins like Shiba Inu and dogwifhat posted double-digit gains despite dips in major cryptocurrencies like Bitcoin and Ethereum. Shiba Inu's rise is partly due to an upcoming airdrop in the Shibarium ecosystem.

Portfolio Pulse from Aniket Verma

May 29, 2024 | 2:52 am

GME

HOOD

NVDA

TSLA

U.S. stocks showed mixed results on Tuesday with the Dow Jones down, S&P 500 slightly up, and Nasdaq gaining. Nvidia, GameStop, Robinhood, Ford, and Tesla were notable stocks on investors' radars. Nvidia saw a significant increase, GameStop rallied after a share offering, Robinhood dipped slightly, Ford fell due to insider selling, and Tesla declined amid lower insurance registrations in China.

Portfolio Pulse from Benzinga Neuro

May 29, 2024 | 2:12 am

GOOG

GOOGL

Economist Paul Krugman has criticized Alphabet Inc.'s Google and other search engines for their declining quality, making his work more challenging. He also labeled AI as 'worse than useless.' This criticism follows reports of user dissatisfaction with Google's AI search features.

Portfolio Pulse from Ananya Gairola

May 29, 2024 | 2:07 am

BTCUSD

DOGEUSD

ETHUSD

NVDA

The cryptocurrency market experienced a decline due to concerns over Mt. Gox's Bitcoin transfers worth billions of dollars. Bitcoin, Ethereum, and Dogecoin all saw price drops. Despite this, Bitcoin's Open Interest rose, indicating bearish sentiment. Nvidia's stock rose, contributing to a mixed performance in the stock market.

Portfolio Pulse from Aniket Verma

May 29, 2024 | 2:00 am

COST

DIS

INTC

NFLX

NVDA

PEP

TSLA

WMT

XOM

Nvidia Corp (NASDAQ: NVDA) has reached new all-time highs, with its market capitalization hitting $2.805 trillion, surpassing the combined value of Tesla, Walmart, Exxon Mobil, Costco, Netflix, PepsiCo, Disney, and Intel. The surge is partly driven by speculation that Elon Musk may use Nvidia products for a supercomputer.

Portfolio Pulse from Chris Katje

May 28, 2024 | 9:53 pm

ISPR

Ispire Technology Inc. (NASDAQ:ISPR) has entered the South African market through an exclusive distribution deal with Dank Pack. This partnership will see Ispire supplying a range of vapor products and accessories to Dank Pack, South Africa's leading supplier of cannabis product packaging and accessories. The deal aims to meet the rising demand for high-quality vaping products in the rapidly-growing South African cannabis market.

Portfolio Pulse from Patricio Liddle

May 28, 2024 | 9:44 pm

BTCUSD

ETHUSD

The U.S. SEC has approved spot Ethereum ETFs, potentially opening the door for new investors. Despite this, a Benzinga poll shows that 50% of Ethereum holders would only sell at $10,000, indicating strong holding sentiment. Ethereum has not yet hit new all-time highs following the ETF approval.

Portfolio Pulse from Chris Katje

May 28, 2024 | 9:35 pm

CTKB

Cytek Biosciences announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received approval from China's National Medical Products Administration (NMPA) for clinical diagnostic use.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 9:34 pm